Healthcare provider profile · identity verified

Howard Leibowitz, MD

Internal Medicine · WORTHINGTON, MN · NPI 1851363121

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	266	55
Levothyroxine Sodium	Levothyroxine Sodium	252	48
Lisinopril	Lisinopril	236	51
Furosemide	Furosemide	232	45
Atorvastatin Calcium	Atorvastatin Calcium	196	39
Omeprazole	Omeprazole	193	45
Metformin Hcl	Metformin Hcl	159	32
Simvastatin	Simvastatin	157	42
Tamsulosin Hcl	Tamsulosin Hcl	157	35
Metoprolol Succinate	Metoprolol Succinate	156	31
Metoprolol Tartrate	Metoprolol Tartrate	142	31
Gabapentin	Gabapentin	140	28
Potassium Chloride	Potassium Chloride	138	22
Tramadol Hcl	Tramadol Hcl	126	30
Losartan Potassium	Losartan Potassium	113	26
Eliquis	Apixaban	112	17
Allopurinol	Allopurinol	108	24
Sertraline Hcl	Sertraline Hcl	100	15
Fluticasone Propionate	Fluticasone Propionate	89	17
Atenolol	Atenolol	88	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	13
Alendronate Sodium	Alendronate Sodium	74	20
Propranolol Hcl	Propranolol Hcl	73	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	70	20
Rosuvastatin Calcium	Rosuvastatin Calcium	69	18
Warfarin Sodium	Warfarin Sodium	69	13
Lorazepam	Lorazepam	63	16
Carvedilol	Carvedilol	60	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	11
Pantoprazole Sodium	Pantoprazole Sodium	58	suppressed
Lactulose	Lactulose	56	suppressed
Clopidogrel	Clopidogrel Bisulfate	54	14
Donepezil Hcl	Donepezil Hcl	52	suppressed
Baclofen	Baclofen	50	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	49	suppressed
Olanzapine	Olanzapine	49	suppressed
Pravastatin Sodium	Pravastatin Sodium	47	13
Albuterol Sulfate Hfa	Albuterol Sulfate	46	18
Azithromycin	Azithromycin	46	33
Bupropion Xl	Bupropion Hcl	44	suppressed
Prednisone	Prednisone	43	suppressed
Trazodone Hcl	Trazodone Hcl	42	suppressed
Famotidine	Famotidine	40	suppressed
Latanoprost	Latanoprost	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Jardiance	Empagliflozin	34	suppressed
Meloxicam	Meloxicam	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Digoxin	Digoxin	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Budesonide	Budesonide	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Sulfasalazine Dr	Sulfasalazine	21	suppressed
Glipizide	Glipizide	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	19	suppressed
Metolazone	Metolazone	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Torsemide	Torsemide	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Roflumilast	Roflumilast	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Linzess	Linaclotide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Farxiga	Dapagliflozin Propanediol	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Methylprednisolone	Methylprednisolone	16	12
Myrbetriq	Mirabegron	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Ozempic	Semaglutide	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error